I agree that this site is using cookies. You can find further informations here.
X
Leong, Ruby
33  results:
Search for persons X
?
1

Study design considerations to assess the impact of potenti..:

Subramaniam, Sriram ; Shord, Stacy S. ; Leong, Ruby...
Clinical and Translational Science.  16 (2023)  5 - p. 719-722 , 2023
Link: https://doi.org/10.1111/..
 
?
2

Utility of Physiologically Based Pharmacokinetic Modeling t..:

Yang, Xinxin ; Grimstein, Manuela ; Pressly, Michelle...
Pharmaceutics.  15 (2023)  12 - p. 2727 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Physiologically Based Pharmacokinetic Modeling of Nilotinib..:

Liu, Xiaomei I. ; Leong, Ruby ; Burckart, Gilbert J..
The Journal of Clinical Pharmacology.  , 2023
Link: https://doi.org/10.1002/..
 
?
4

Landscape and Regulatory Perspective on Oncology Drugs in P..:

Leong, Ruby ; Grimstein, Manuela ; DeMaria, Peter...
The Journal of Clinical Pharmacology.  63 (2023)  S1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
5

FDA approval summary: Crizotinib for pediatric and young ad..:

Merino, Margret ; Kasamon, Yvette ; Li, Hongshan...
Pediatric Blood & Cancer.  69 (2022)  8 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
6

Recommendations for Dose Selection for Adolescent Patients ..:

Leong, Ruby ; Liu, Qi ; Li, Lingjue...
Clinical Pharmacology & Therapeutics.  111 (2021)  4 - p. 956-963 , 2021
Link: https://doi.org/10.1002/..
 
?
7

FDA Approval Summary: Ruxolitinib for Treatment of Steroid-..:

Przepiorka, Donna ; Luo, Lola ; Subramaniam, Sriram...
The Oncologist.  25 (2019)  2 - p. e328-e334 , 2019
Link: https://doi.org/10.1634/..
 
?
8

Bridging Adult Experience to Pediatrics in Oncology Drug De..:

Leong, Ruby ; Zhao, Hong ; Reaman, Gregory...
The Journal of Clinical Pharmacology.  57 (2017)  S10 - p. , 2017
Link: https://doi.org/10.1002/..
 
?
9

Pediatric Development of Molecularly Targeted Oncology Drug:

Patel, Shivam Kamlesh ; Leong, Ruby ; Zhao, Hong...
Clinical Pharmacology & Therapeutics.  104 (2017)  2 - p. 384-389 , 2017
Link: https://doi.org/10.1002/..
 
?
10

Methodological Issues in the Design of Paediatric Pharmacok..:

Burckart, Gilbert J. ; Estes, Kristina E. ; Leong, Ruby...
Pharmaceutical Medicine.  26 (2012)  1 - p. 13-22 , 2012
Link: https://doi.org/10.1007/..
 
?
11

Utility of Physiologically Based Pharmacokinetic Modeling t..:

Yang, Xinxin ; Grimstein, Manuela ; Pressly, Michelle...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10748010/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

FDA Approval Summary: Oral Azacitidine For Continued Treatm..:

Jen, Emily Y ; Wang, Xin ; Li, Meng...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288471/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

FDA Approval Summary: Ruxolitinib for Treatment of Chronic ..:

Le, Robert Q ; Wang, Xin ; Zhang, Hongfei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177119/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐..:

Przepiorka, Donna ; Luo, Lola ; Subramaniam, Sriram...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011641/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

Evaluation of pharmacokinetics, user handling, and tolerabi..:

Varunok, Peter ; Lawitz, Eric ; Beavers, Kimberly L...
info:eu-repo/semantics/altIdentifier/doi/10.2147/PPA.S26566.  , 2011
Link: https://www.dovepress.co..
 
1-15